Facebook
Twitter
Telegram
Report an ErrorOutlook Therapeutics Financial Ratios 2011-2024 | OTLK
Annual Financial Ratios Outlook Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.8 | -3.5 | -2.9 | -1.6 | -0.6 | -1.2 | -0.8 | -1.3 | - | - | - | - | - |
P/S |
- | - | -3294.7 | - | 2.7 | 11.5 | 8.4 | 24.1 | - | - | - | - | - |
EPS |
-0.2 | -0.3 | -0.3 | -0.7 | -2.0 | -1.2 | -1.7 | -3.7 | -5.4 | - | - | - | - |
EV (Enterprise Value) |
128 M | 234 M | 156 M | 61 M | 42 M | 76.9 M | 80.5 M | 98.5 M | 26.1 M | 64.3 M | - | - | - |
EBITDA per Share |
-0.21 | -0.3 | -0.34 | -0.493 | -1.19 | -5.39 | -11.1 | -22.9 | - | - | - | - | - |
EV/EBITDA |
-3.0 | -1.4 | -1.2 | -1.9 | -1.4 | -1.6 | - | - | - | - | - | ||
PEG |
0.04 | 0.08 | 0.05 | -0.02 | -0.01 | -0.04 | -0.02 | 0.14 | - | - | - | - | - |
P/B |
-7.3 | 26.5 | 33.1 | 20.0 | -2.0 | -1.7 | -1.0 | -13.8 | - | - | - | - | - |
P/CF |
-2.4 | -4.1 | -2.8 | -1.8 | -0.7 | -1.0 | -2.0 | -1.5 | - | - | - | - | - |
ROE % |
408.53 | -756.04 | -1153.86 | -1246.85 | 320.56 | 144.60 | 126.44 | 1025.53 | - | - | - | - | - |
ROA % |
-182.61 | -231.54 | -233.06 | -178.59 | -201.48 | -135.04 | -187.37 | -224.96 | - | - | - | - | - |
ROCE % |
367.97 | -721.92 | -1122.68 | -944.73 | 793.26 | 303.78 | 448.29 | -1583.27 | - | - | - | - | - |
Current Ratio |
0.7 | 1.4 | 1.3 | 1.1 | 0.7 | 0.1 | 0.1 | 0.3 | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Outlook Therapeutics
| 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.04 | - | -0.08 | -0.03 | -0.08 | -0.25 | -0.08 | -0.09 | -0.08 | -0.27 | -0.07 | -0.09 | -0.12 | -0.69 | -0.03 | -0.36 | -0.62 | -1.74 | -0.2 | -0.62 | -1 | -9.96 | -0.26 | -0.33 | -0.71 | -1.37 | -0.22 | -0.34 | -0.82 | -3.43 | -1.6 | -0.32 | -1.36 | -3.67 | -1.3 | -1.61 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.04 | - | - | - | -0.07 | -0.22 | -0.08 | -0.09 | -0.07 | -0.26 | -0.07 | -0.08 | -0.12 | -0.47 | -0.13 | -0.29 | -0.27 | -1.43 | -0.21 | -0.25 | -0.96 | -4.22 | -0.19 | -0.37 | -0.1 | -1.3 | -0.27 | -0.11 | -0.74 | -2.58 | -1.14 | -1.22 | -1.21 | -3 | -1.11 | -1.47 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
733.90 | 193.84 | -398.01 | -861.07 | -852.41 | -763.60 | -1034.68 | -1043.01 | -1051.68 | -884.06 | -916.93 | -792.48 | -591.01 | -675.34 | 371.91 | 370.66 | 286.33 | 269.62 | 188.22 | 193.69 | 178.15 | 148.84 | 175.31 | 158.14 | 125.71 | 205.54 | 935.14 | 1348.66 | 1710.22 | 1678.50 | 908.14 | 499.69 | 76.67 | 76.67 | 20.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-156.90 | -88.60 | -269.86 | -268.79 | -285.59 | -274.20 | -267.24 | -258.88 | -287.22 | -384.32 | -338.33 | -316.52 | -332.32 | -376.13 | -390.39 | -401.03 | -424.66 | -317.44 | -255.17 | -267.10 | -213.92 | -167.80 | -244.14 | -232.01 | -197.56 | -285.02 | -296.59 | -365.06 | -436.36 | -429.30 | -347.44 | -285.65 | -118.74 | -118.74 | -32.39 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
636.55 | 164.92 | -396.89 | -811.34 | -798.72 | -726.10 | -995.36 | -1000.59 | -1009.15 | -846.74 | -964.86 | -761.45 | -564.84 | -673.85 | 421.70 | 343.29 | 234.27 | 246.73 | 167.82 | 161.09 | 174.79 | 148.54 | 179.07 | 172.61 | 141.90 | 210.74 | 912.98 | 1314.77 | 1649.50 | 1621.83 | 875.45 | 472.23 | 74.21 | 74.21 | 20.37 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.5 | 0.7 | 0.9 | 1.2 | 1.3 | 1.4 | 2.1 | 2.1 | 2.6 | 1.2 | 1.6 | 1.2 | 0.5 | 1.2 | 1.2 | 1.2 | 0.3 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.8 | 0.4 | 0.4 | 0.4 | 0.5 | 0.8 | 0.8 | 0.8 | - | 0.6 | 0.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.1 | 46.9 | 76.0 | 0.9 | 0.4 | 0.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.1 | 46.9 | 76.0 | 0.9 | 0.4 | 0.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.1 | 46.9 | 76.0 | 0.9 | 0.4 | 0.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency